Thank you for visiting our booth at MEDICA 2019
As the world's largest trade fair for the medical industry, Medica 2019 marked another success this year in Düsseldorf / Germany 18 - 21 November.GY Highland Biotech LLC booth was…
Application of folate receptor-mediated cervical epithelial tissue specific staining in screening cervical cancer
ZHANG Chunhua, WU Ling, YANG hui, et al. Deparment of Gynecology, Huaian Maternity and Child Health Care Hospital, Huaian, 223002, CHINA Abstract Objective To investigate the application value of folate…
A special epithelial staining agent: Folate Receptor-mediated Detection (FRD™) effectively and conveniently screens patients with cervical cancer
Meng-han Lu, Ling-yun Hu, Xin-xin Du, Min Yang, Wei-yi Zhang, Ke Huang, Li-an Li, Ya-li Li, Shu-fang Jiang* (The Department of Gynecology & Obstetrics, The Chinese People's Liberation Army General…
The development of screening, diagnosis and management with abnormal Pap test results
Wojciech Homola (ABCDEF), Tomasz Fuchs (ABDEF), Michał Pomorski (ADEF), Anna Rosner-Tenerowicz (BDEF), Mariusz Zimmer (ADEF)2nd Department of Obstetrics and Gynecology, Wroclaw Medical University, Wroclaw, PolandCervical cancer is a significant oncological…
Clinical application of a rapid cervical cancer screening method: Folate receptor–mediated staining of cervical neoplastic epithelia
Donghong LI,¹ Lihong CHEN,² Huifang WANG,³ Hongli YANG,⁴ Yuping DAI,¹ Cuige YU² and Yun DONG⁵AbstractAim: A newly developed cervical cancer screening method – folate receptor–mediated epithelium staining utilizes methylene blue…
Compare two different usages of FRD™ for detecting high‐grade cervical lesions and invasive cancer
Yuping Dai¹ · Lirong Wang¹ · Donghong Li² Received: 25 May 2017 / Accepted: 2 February 2019 © Springer-Verlag GmbH Germany, part of Springer Nature 2019 Abstract Objective To evaluate…
Effectiveness of novel folate receptor-mediated staining solution detection (FRD™) for cervical cancer screening
Yuping Dai, MDᵃ, Lirong Wangᵃ, Donghong Liᵇ,∗AbstractFolate receptor-mediated staining solution detection (FRD™) has been recently suggested as an effective tool in the cervical cancer screening. We aim to compare the…
Dr. Shashi Joshi inspects the result of FRD™ cervical lesions
Dr. Shashi Joshi inspects the result of FRD™ cervical lesionsOctober 9th, 2019 Dr. Shashi Joshi inspects the result of FRD™ cervical lesion screening at HADI Clinic in Jabriya, Kuwait during…
FRD™ Introductory Course at Newark Beth Israel Medical Center
Newark Beth Israel Medical Center is the largest hospital in Newark, New Jersey. It was run under auspices of the Newark Jewish Community and in 2011, the Newark Beth Israel…
